These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21978260)

  • 1. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
    Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
    Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
    Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
    Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of transportan 10 in PEI mediated plasmid delivery assay.
    Kilk K; El-Andaloussi S; Järver P; Meikas A; Valkna A; Bartfai T; Kogerman P; Metsis M; Langel U
    J Control Release; 2005 Mar; 103(2):511-23. PubMed ID: 15763630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of cell-penetrating peptide-mediated peptide delivery.
    Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
    Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
    Mäe M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
    J Control Release; 2009 Mar; 134(3):221-7. PubMed ID: 19105971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of stearyl and trifluoromethylquinoline modifications of the cell penetrating peptide TP10 on its interaction with a lipid membrane.
    Anko M; Majhenc J; Kogej K; Sillard R; Langel U; Anderluh G; Zorko M
    Biochim Biophys Acta; 2012 Mar; 1818(3):915-24. PubMed ID: 22240008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity, Immunogenicity, Uptake, and Kinetics Methods for CPPs.
    Uusna J; Langel K; Langel Ü
    Methods Mol Biol; 2015; 1324():133-48. PubMed ID: 26202267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
    Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
    Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake of transportan 10 and its analogs in live cells: Selectivity and structure-activity relationship studies.
    Song J; Kai M; Zhang W; Zhang J; Liu L; Zhang B; Liu X; Wang R
    Peptides; 2011 Sep; 32(9):1934-41. PubMed ID: 21827806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
    Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
    J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
    El-Andaloussi S; Järver P; Johansson HJ; Langel U
    Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
    Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
    J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context.
    Vadori M; Seveso M; Besenzon F; Bosio E; Tognato E; Fante F; Boldrin M; Gavasso S; Ravarotto L; Mann BE; Simioni P; Ancona E; Motterlini R; Cozzi E
    Xenotransplantation; 2009; 16(2):99-114. PubMed ID: 19392725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
    Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.
    Eriksson OS; Geörg M; Sjölinder H; Sillard R; Lindberg S; Langel U; Jonsson AB
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3704-12. PubMed ID: 23689723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.